- Home
- BR vs BNTX Comparison
BR vs BNTX Comparison
Compare BR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BR | BNTX |
|---|---|---|
| Founded | 1962 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.7B | 24.7B |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BR | BNTX |
|---|---|---|
| Price | $166.43 | $96.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 21 |
| Target Price | ★ $213.38 | $116.31 |
| AVG Volume (30 Days) | ★ 861.5K | 826.4K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | ★ 35.21 | N/A |
| EPS | ★ 9.60 | N/A |
| Revenue | ★ $4,142,600,000.00 | N/A |
| Revenue This Year | $5.06 | N/A |
| Revenue Next Year | $4.94 | $0.51 |
| P/E Ratio | $17.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $133.83 | $79.81 |
| 52 Week High | $236.02 | $124.00 |
Technical Indicators
Market Signals| Indicator | BR | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 47.63 |
| Support Level | $164.21 | $95.32 |
| Resistance Level | $176.94 | $98.81 |
| Average True Range (ATR) | 3.10 | 2.97 |
| MACD | 0.67 | -0.22 |
| Stochastic Oscillator | 89.84 | 51.65 |
Price Performance
Historical ComparisonAbout BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.